Question 1

What are the expected benefits of this treatment compared to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer clinical trial (NCT00192036). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I be aware of with this combination of treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer clinical trial (NCT00192036). Contact the study team or your healthcare provider for specific answers.

Question 3

How will this treatment fit into my overall care plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer clinical trial (NCT00192036). Contact the study team or your healthcare provider for specific answers.

Question 4

What kind of monitoring will I need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer clinical trial (NCT00192036). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any travel requirements for participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer clinical trial (NCT00192036). Contact the study team or your healthcare provider for specific answers.

What this study is about